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doi:10.1016/j.jprot.2010.01.014A B S T R A C TKeywords: Contractile weakness and loss of muscle mass are critical features of the aging process in
mammalians. Age-related fibre wasting has a profound effect on muscle metabolism, fibre
type distribution and the overall physiological integrity of the neuromuscular system. This
study has used mass spectrometry-based proteomics to investigate the fate of the aging rat
muscle proteome. Using nonionic detergent phase extraction, this report shows that the
aged gastrocnemius muscle exhibits a generally perturbed protein expression pattern in
both the detergent-extracted fraction and the aqueous protein complement from senescent
muscle tissue. In the detergent-extracted fraction, the expression of ATP synthase, isocitrate
dehydrogenase, enolase, tropomyosin and beta-actin was increased. Different isoforms of
creatine kinase and prohibitin showed differential changes. In the aqueous fraction, malate
dehydrogenase, sulfotransferase, triosephosphate isomerase, aldolase, cofilin-2 and lactate
dehydrogenase showed increased levels. Interestingly, differential effects on dissimilar 2-D
spots of the same protein species were shown for Cu/Zn superoxide dismutase, albumin,
annexin A4 and phosphoglycolate phosphatase. Mitochondrial Hsp60, Hsp71 and
nucleoside diphosphate kinase B exhibited a reduced abundance in aged muscle. The
majority of altered proteins were found to be involved in mitochondrial metabolism,
glycolysis, metabolic transportation, regulatory processes, the cellular stress response,
detoxification mechanisms and muscle contraction.
© 2010 Elsevier B.V. All rights reserved.Aging
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DIGE
Muscle proteomics
Sarcopenia1. Introduction
Natural aging is a fundamental biological process [1], whereby
one of the most striking features of the senescent body is the
loss in muscle mass and function [2]. Age-related contractile
weakness has been termed sarcopenia of old age and is
probably indirectly involved in many physiological and; fax: +353 1 708 3845.
(K. Ohlendieck).
ody of work.
er B.V. All rights reservedmetabolic alterations in the aging organism [3–5]. Denervation
probably plays a key role in the age-dependent shift to a
slower-twitching phenotype [6]. Although longitudinal studies
indicate that contractile function may be preserved in single
human muscle fibres [7], it has clearly been established
that significant alterations occur at the whole-muscle level
[8]. The age-related reduction in cross-sectional muscle area.
1442 J O U R N A L O F P R O T E O M I C S 7 3 ( 2 0 1 0 ) 1 4 4 1 – 1 4 5 3correlates relatively well with the decreased specific force of
senescent muscles [9]. A variety of cross-sectional studies
agree that the tissue mass of the aged musculature decreases
dramatically. It is estimated that 15 to 42% of muscle mass is
lost between the ages of 20 and 80 [10–12].
Several mass spectrometry-based proteomic studies have
investigated changes in the protein complement of aging
skeletal muscles over the last few years, as reviewed by Doran
et al. [13]. These proteomic profiling studies have focused on
crude soluble extracts and have shown that muscle aging is
associated with altered expression levels of many key
contractile proteins, regulatory elements, ion handling pro-
teins, metabolic enzymes and mediators of the cellular stress
response [14–20]. The proteomic finding of a drastically
decreased density and reduced enzymatic activity of certain
glycolytic enzymes in senescent fibres [21] is in agreement
with the idea of a fast-to-slow transformation process during
aging [13]. In analogy, proteomic surveys clearly revealed
increased levels of mitochondrial enzymes and metabolite
transporters of aerobic metabolism in aged muscle [22]. Thus,
fibre shifting to slower twitch characteristics with a more
oxidative bioenergetic profile appears to occur in the aging
neuromuscular system. Recently, comparative subproteomics
of the soluble myofibril-enriched fraction has shown distinct
age-dependent effects on the contractile apparatus. The
contractile protein exhibiting the most drastically changed
expression was identified as the MLC2 isoform of the slow-
type myosin light chain [23], which also exhibits enhanced
phosphorylation levels in aged fibres [24]. Although fast and
slow isoforms of myosin heavy chain switch in themajority of
aged fibres, the dramatic increase in slow MLC2 expression
was restricted to individual senescent cells [23]. Since post-
translational modifications play a central role in protein
function and considerably increase protein diversity within
the skeletal muscle proteome, it is important to stress that
glycosylation, tyrosine nitration, and tyrosine/threonine
phosphorylation are generally altered in senescent skeletal
muscles [21,24,25], thereby complicating global protein ex-
pression analysis.
Building on the proteomic findings from the above described
surveys of total crude muscle extracts [13], this study has
focused on the proteomic profiling of senescent muscle tissue
with respect to the aqueous versus the detergent-extracted
fraction. Nonionic detergent phase extraction was carried out
with Triton X-114. This detergent is ideal for the phase
partitioning of soluble and membrane-associated muscle pro-
teins, as fractionated proteins are not degraded or excessively
denatured [26,27]. The method was previously validated in
cardiac tissue and resulted in two distinct subproteomes by
partitioning soluble and membrane-associated proteins into
aqueous and detergent phases, respectively [27]. Here, 2-D
fluorescence DIGE analysis [28] was used to compare the young
adult versus the senescent rat gastrocnemiusmuscle. Following
the gel electrophoretic separation of the aqueous and the
detergent-extracted fraction from skeletal muscle homoge-
nates, proteins of interest with a changed abundance were
identifiedbyMALDI-ToFMS,MALDI-ToF/ToFMSandESI LC–MS/
MS technology. Several new potential markers of muscle aging
were identified which might be useful for the future establish-
ment of a comprehensive biomarker signature of sarcopenia.2. Materials and methods
2.1. Materials
CyDye DIGE Fluor minimal dyes Cy3 and Cy5, ampholytes,
cover fluid, acetonitrile, the Plus-One silver-staining kit, and
immobilised pH gradient (IPG) drystrips for 2-DE were
obtained from Amersham Bioscience/GE Healthcare (Little
Chalfont, Bucks, UK). Sequencing grade-modified trypsin was
purchased from Promega (Madison, WI, USA). LC–MS Chro-
masolv water and formic acid were from Fluka (Milwaukee,
WI, USA). Acrylamide stock solutions were purchased from
National Diagnostics (Atlanta, GA, USA). GE buffer systems,
protein molecular weight ladders and Bradford reagent were
obtained from Biorad Laboratories (Hemel-Hempstead, Herts.,
UK). Protease inhibitors were from Roche Diagnostics (Man-
nheim, Germany). Nitrocellulose transfer stacks were
obtained from Invitrogen (Carlsbad, CA, USA). Chemilumines-
cence substrate was purchased from Roche Diagnostics
(Mannheim, Germany). Primary and secondary antibodies
were obtained from various commercial sources, as listed in
previous studies [16–18]. Ultrapure lysine for quenching the
DIGE labeling reaction and all other analytical-grade chemi-
cals were purchased from Sigma Chemical Company (Dorset,
UK).
2.2. Nonionic detergent phase extraction of muscle
proteins
Fractionation of crude skeletalmuscle tissue preparations into
an aqueous phase and a detergent-extracted phase was
carried out as previously described for cardiac muscle [27].
Freshly dissected gastrocnemius muscle tissue (250 mg) from
3 Wistar rats each of 3-month and 26-month of age were
ground into a fine powder under liquid nitrogen using a pestle
and mortar. The age groups studied represent young adult
animals versus senescent rats [16–18]. Ground tissue was
immediately added to 8 ml of ice-cold phosphate buffered
saline (PBS; 0.9% (w/v) NaCl, 50 mM sodium phosphate, pH 7.4)
and 2 ml of 10% (v/v) Triton X-114 and left overnight at 4 °C on
a rotary shaker. The suspended samples were centrifuged at
20,000 g for 30 min at 4 °C to remove tissue debris. The
supernatant was incubated for 30 min at 37 °C and then
centrifuged for 5000 g at 25 °C to separate detergent and
aqueous phases. The aqueous top layer was removed to a
fresh 50ml tube to which 2 ml of 10% (v/v) Triton X-114 was
added. The lower detergent-extracted phase was resuspended
in 8 ml of ice-cold PBS. Both samples were placed for 15min at
37 °C, followed by a 15min centrifuge spin at 5000 g and 25 °C.
Thisprocesswas repeated3 times inorder towasheach fraction
and remove potential cross-contaminants. Differently separat-
ed proteins were extracted from each phase by acetone
precipitation at −20 °C for 1 h. Following a centrifugation step
at 5000 g for 30min, precipitated proteins were resuspended in
1 ml buffer and 200 µl of DIGE-compatible lysis buffer [18]. The
total protein yield from starting material of 250 mg of
skeletal muscle tissue was 5.16±0.38 mg in the young AQ
phase (n=5), 4.78±0.62 mg in the old AQ phase (n=5), 0.45±
0.10 mg in the young DT phase (n=5) and 0.40±0.09 mg in the
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by the Bradford dye-binding assay [29].
2.3. Gel electrophoretic analysis
For the comparative proteomic analysis of proteins fractionated
into AQ phase and DT phase, minimal fluorescent dye labeling
was performed at a ratio of 25 µg of protein per 200 pmol of
CyDye as previously described [30], following the recommenda-
tionsofKarpandco-workers foroptimizedDIGEanalysis [31,32].
Labeled samples were incubated on ice for 30min in the dark.
The labeling reaction was terminated by the addition of 10 mM
lysine [18]. Labeled protein extracts were utilized immediately
for further analysis or otherwise stored at −80 °C. Protein
samples, for separation over a pH 4–7 gradient, were combined
with an equal volume of 2× lysis buffer (9.5 M urea, 2% (w/v)
CHAPS, 2% (w/v) DTTand 1.6%Pharmalyte pH3–10), followedby
in-gel rehydration overnight prior to isoelectric focusing. A final
strip volume of 450 µl was achieved through the addition of
rehydration buffer (8 M urea, 0.5% (w/v) CHAPS, 0.2% (w/v) DTT
and 0.2% w/v Pharmalyte pH 3–10). First dimension gel
electrophoretic separation was performed at 0.05mA/IPG strip
for 75.000 Vh, using 8000 V for 10min and 8000 V for 1 h at 20 °C.
Basic IPGphor strips (18 cm pH 6–11) were prehyrated in 300 µl
basic rehydration buffer (8 M urea, 0.5% (w/v) CHAPS, 0.2% (w/v)
DTT and 1.2% DeStreak Reagent) overnight at room tempera-
ture. Protein samples, for separation over a pH 6–11 gradient,
were combined with an equal volume of 2× lysis buffer (9.5 M
urea, 2% (w/v) CHAPS, 2% (w/v)DTTand1.2%DeStreakReagent).
Final sample volume was brought up to 100 µl in basic re-
hydration buffer and actively paper bridge loaded onto pH 6–11
IPG strips for 16 h at 200 V [33]. Following active paper bridge
sample loading, all wicks were changed. IEF was performed at
0.05mA/IPG strip at 300 V for 2 h, 600 V for 2 h, 1000 V for 1 h,
8000 V for 1 h and finally 8000 V to achieve 50.000 Vh. All
focused IPG strips were immediately used for the 2D separation
step or frozen and stored at −80 °C. Strip equilibration was
carried out in 10ml/strip of equilibration buffer (6 M (w/v) urea,
30% (v/v) glycerol, 2% (w/v) SDS, 0.05 MTris–HCl, pH8.8 and0.1%
(w/v) bromophenol blue) with the addition of 1% (w/v) DTT for
15min. Subsequently 5% (w/v) iodoacetamide was added to the
above equilibration buffer with strip incubation for a further
15min. 2-Dseparationwas carriedoutat 1 W/gel forapprox24 h
using a Protean Plus Dodeca cell system (Biorad Laboratories
(Hemel-Hempstead, Herts., UK) at 15 °C and was terminated
when the dye front had just migrated off the lower end of the
gels. A total of 24 gels were analyzed over pH 4–7 and pH 6–11
ranges. This covered both young adult and aged gastrocnemius
specimenswith respect toAQ-andDT-phase-enrichedproteins.
Gels were scanned using a Typhoon variablemode imager 9400
(Amersham Bioscience/GE Healthcare, Little Chalfont, Bucks,
UK), with a standard pixel volume of 60 K–80 K for all scans. The
isolation of crude extracts from skeletal muscle tissue, 1-D gel
electrophoresis, and silver staining of 1D or 2D gels was carried
out as previously described in detail [22].
2.4. Expression analysis
Following nonionic detergent phase extraction of muscle
proteins, DIGE labeling and 2-DE separation, protein expres-sion changes between young adult and aged samples from
the AQ and DT fractions were analyzed using Progenesis
SameSpots analysis software from Non Linear Dynamics
(Newcastle upon Tyne, UK). Prior to analysis, individual gels
were warped to a single master gel and further matched and
normalized with non-gel spots manually filtered out on the
basis of spot volume. SameSpots analysis (SSA) was used to
identify proteins of interest using the following parameters:
n=5; ANOVA p<0.05; t-test p<0.05; and a power value of >0.8.
Proteins with a significantly changed abundance were
picked for tryptic digestion from silver-stained preparative
gels.
2.5. Protein digestion
Excised protein spots from 2-DE gels were added to 200 mM
ammonium bicarbonate solution and incubated at 37 °C for
10 min with gentle agitation. Following a brief spin, a
solution of 200 mM ammonium bicarbonate/acetonitrile 2:3
was added to each gel plug and left at 37 °C for 10 min with
gentle agitation. Samples were spun again briefly and
resuspended in 50 mM ammonium bicarbonate and left at
37 °C for 10 min with gentle agitation. Gel plugs were shrunk
using 100% acetonitrile for 10 min at 37 °C. Proteins were
digested overnight at 37 °C with gentle agitation using 0.2 ng/
μl of sequence grade-modified trypsin (Promega, Madison,
WI, USA). Peptides were recovered by removing supernatants
from digested gel plugs. Further recovery was achieved by
adding 30% acetonitrile/0.2% trifluoric acid to the gel plugs
for 10 min at 37 °C with gentle agitation. Following a brief
spin, supernatants were added to the initial peptide re-
covery following digestion. Exhaustive peptide recovery was
achieved through the addition of 60% acetonitrile/0.2%
trifluoric acid to each plug for 10 min at 37 °C with gentle
agitation. Supernatants were added to the peptide pool.
Sample volume was reduced until dry through vacuum
centrifugation. Samples were resuspended in 30 μl of ultra-
pure ddH2O and 0.1% formic acid for identification by mass
spectrometry.
2.6. ESI LC–MS/MS analysis
ESI LC–MS/MS analysis was carried out in the Proteomics
Suite of the National University of Ireland, Maynooth.
Nanoflow LC separation of tryptic peptides was performed
with a nanoflow 1200 series system from Agilent Tech-
nologies (Santa Clara, CA, USA), equipped with a Zorbax
300SB C18 5 µm, 4 mm 40 nl pre-column and an Zorbax
300SB C18 5 µm, 43 mm×75 µm analytical reversed phase
column using HPLC-Chip technology. Samples were initially
transferred with an aqueous 0.1% formic acid solution to a pre-
column with a flow rate of 4 µl/min for 3 min. Mobile phase
A was 0.1% formic acid and mobile phase B 0.1% formic acid
in acetonitrile. Peptides were separated with a gradient of 3
to 40% mobile phase B over 40min at a flow rate of 400 µl/min,
followed by a 10min wash with 90% of mobile phase B. The
column was re-equilibrated at initial conditions for 10 min.
Injection volume of 20 µl was used per sample. Analysis of
tryptic peptides was performed using an Agilent 6300 series ion
trap LC mass spectrometer. All analyses were performed using
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was set between 100 and 2200m/z with a duration of 0.5 s/
scan and the 3 most intense peptides further selected for MS
analysis. Collision energywas ramped between 1500 and 4500 V
based on the observed precursor mass over charge value and
charge state. Spectrawere processed and analyzed by Spectrum
Mill database search software (Agilent Technologies, Santa
Barbara, CA).
2.7. MALDI-ToF/ToF MS analysis
MALDI-ToF MS analysis was performed in the Proteome
Research Centre of the Conway Institute, University College
Dublin. MALDI-ToF and MALDI-ToF/ToF mass spectrometric
analyses were carried out with a 4800 plus MALDI ToF/ToF
Analyzer (Applied Biosystems, Foster City, CA). Peptide
masses were acquired over a range from 800 to 4000 m/z,
with a focus mass of 2000 m/z. MS spectra were summed from
2500 laser shots from an Nd:YAG laser operating at 355 nm
and 200 Hz. Calibration was performed using peptide stan-
dards (masses 900–2400 m/z; Applied Biosystems). A maxi-
mum of 12 precursors per sample well with a signal-to-noise
ratio of >20 were automatically selected for subsequent
fragmentation by collision induced dissociation. MS/MS spec-
tra were summed from 2000 laser shots. Spectra were
processed and analyzed by the Global Protein Server Work-
station (Applied Biosystems).
2.8. Immunoblot analysis
Immunodecoration of proteins of interest was carried out by
1-D immunoblot analysis as previously described in detail [17].
Following the electrophoretic transfer of proteins to nitrocel-
lulose membranes, sheets were blocked in a milk protein
solution for 1 h and then incubated overnight with gentle
agitation with primary antibody, sufficiently diluted in block-
ing solution containing 5% (w/v) fat-free milk powder in
phosphate buffered saline (PBS; 0.9% (w/v) NaCl, 50 mM
sodium phosphate, pH 7.4). Primary antibodies were obtained
from Affinity Bioreagents, Golden, CO, USA (mAb MA3-912 to
the fast SERCA1 isoform of the sarcoplasmic reticulum Ca2+-
ATPase; and mAb MA3-913 to the fast CSQf isoform of
calsequestrin), StressGen Bioreagents, Victoria, Canada (pAb
SPA-801 to heat shock protein Hsp25) and Abcam Ltd.,
Cambridge, UK (pAb ab28172 to the mitochondrial marker
protein prohibitin; pAb ab48139 to succinate dehydrogenase,
pAb ab34830 to malate dehydrogenase; and mAb ab14730 to
mitochondrial ATP synthase). Subsequently, blots were
washed twice with blocking solution for 10 min before
incubation for 1 h with secondary peroxidase-conjugated
antibodies, diluted in blocking solution. Secondary antibodies
were purchased from Chemicon International (Temecula, CA,
USA). Following further washing steps with blocking solution
and then two rinsing steps with PBS, antibody-decorated
bands were visualized by the enhanced chemiluminescence
method following the manufacturer's recommendations
(Roche Diagnostics, Mannheim, Germany). Densitometric
scanning of immunoblots was performed on a Molecular
Dynamics 300S computing densitometer (Sunnyvale, CA, USA)
with Imagequant V3.0 software [22].3. Results
3.1. Nonionic detergent phase extraction for the proteomic
analysis of aged skeletal muscle
The subproteomic investigation described here is based on the
principle of nonionic detergent phase extraction [26]. A
comparison of the aqueous versus the detergent-extracted
fraction from young adult versus senescent rat gastrocnemius
muscle tissue was carried out. Fig. 1A outlines the experi-
mental protocol used for the separation of skeletal muscle
proteins by treatment with Triton X-114. Since phase separa-
tion with Triton X-114 occurs at temperatures above 22 °C,
skeletal muscle protein fractionation was carried out at 37 °C
[27]. The separation step resulted in an aqueous AQ phase-
enriched in hydrophilic proteins and a detergent DT phase
with predominantly hydrophobic proteins. Despite repeated
washing steps, phase transition approaches always result in a
certain degree of cross-contamination between soluble and
membrane-associated proteins. Extracted proteins were sep-
arated by standard 2-DE and proteins of interest identified by
MS technology.
3.2. Gel electrophoretic analysis of nonionic detergent
phase extraction of muscle proteins
Fig. 1B–E illustrates the successful enrichment of typical
membrane-associated skeletal muscle proteins in the deter-
gent-extracted fraction and a soluble enzyme in the aqueous
phase-extracted fraction. The 1-DE analysis of crude prepara-
tions versus the aqueous phase versus the detergent-
extracted phase demonstrated the differing protein band
pattern between the two main fractions following phase
separation (Fig. 1B). Importantly, immunoblotting revealed a
clear enrichment of the fast-twitch sarcoplasmic reticulum
Ca2+-ATPase isoform SERCA1 (Fig. 1C) and the inner mito-
chondrial membrane-associated enzyme ATP synthase
(Fig. 1E) in the detergent-extracted fraction from both young
adult and aged muscle tissue. In stark contrast, the soluble
isoform of cytosolicmalate dehydrogenase (Fig. 1D) was found
to be enriched in the aqueous phase from both young adult
and aged muscle tissue. Following the initial evaluation of the
nonionic detergent phase extraction method by 1-DE, the
aqueous and detergent fractions were electrophoretically
separated on large high-resolution 2-DE gels covering the pH
4–7 and pH 6–11 range in the first dimension. Fig. 2 gives an
overview of the considerably different expression patterns of
muscle proteins derived from the aqueous versus the deter-
gent phase. Since silver staining exhibits a relatively limited
dynamic range, the more discriminatory DIGE method was
employed for a detailed determination of changes in protein
abundance due to fibre aging.
3.3. DIGE analysis of the aged muscle proteome
Fluorescent DIGE is one of the most powerful biochemical
tools for conducting comparative expression studies of
complex proteomes, making it an ideal approach for a refined
analysis of the detergent-enriched fraction from young adult
Fig. 1 – Nonionic detergent phase extraction of young adult versus old muscle tissue. The subcellular fractionation approach
used in this subproteomic investigation is based on the principle of nonionic detergent phase extraction. The flowchart in panel
(A) outlines the experimental protocol employed for the separation of skeletal muscle proteins by treatment with Triton X-114.
The temperature-dependent separation step resulted in an aqueous (AQ) phase-enriched in hydrophilic proteins and a
detergent (DT) phase with predominantly hydrophobic proteins. Panel (B) shows a silver-stained 1-D SDS-PAGE gel of muscle
protein fractions (100 μg of protein/gel lane) following nonionic detergent phase extraction. Lane 1 representsmolecularweight
markers (MW). Lanes 2 to 7 represent crude preparations from young muscle (YC), crude preparations from old muscle (OC),
aqueous phase-enriched proteins from young muscle (YAQ), aqueous phase-enriched proteins from old muscle (OAQ),
detergent phase-enriched proteins from young muscle (YDT) and detergent phase-enriched proteins from old muscle (ODT),
respectively. Panels (C) to (E) show corresponding immunoblots labeled with antibodies to the integral SERCA1 isoform of the
sarcoplasmic reticulumCa2+-ATPase, the cytosolic isoform ofmalate dehydrogenase (MDH) and themitochondrial enzymeATP
synthase, respectively. 30 μg of protein was loaded per gel lane. The distinct subcellular fractionation of the integral versus
soluble marker proteins during the detergent phase extraction procedures agrees with the idea of a successful separation of
hydrophobic versus hydrophilic muscle proteins.
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accurate quantitative technique that enables multiple protein
samples to be separated in parallel on the same 2-DE gel,
thereby greatly reducing the introduction of potential artifacts
due to gel-to-gel variations [28]. Following scanning with an
Amersham Typhoon Trio variable imager and with the help of
Progenesis 2-D analysis software, 94 protein species out of
2865 detectable 2-D spots were found to be differentially
expressed. DIGE master gels representing electrophoretically
separated proteins from young adult versus senescent muscle
fibres are shown for the pH 4–7 (Figs. 3A and 4A) and the pH 6–
11 (Figs. 3B and 4B) range. The lower and higher pH-scale of thetwo different IEF approaches resulted in the separation of 657
and 371 protein spots in the detergent phase, and 1464 and 373
protein spots in the aqueous phase, respectively. The number
of proteins that exhibited a changed abundance was 23, 15, 37
and 19 for the pH 4–7 DT phase, pH 6–11 DT phase, pH 4–7 AQ
phase and pH 6–11 AQ phase, respectively. Proteins of interest
were identified by mass spectrometry.
3.4. Proteomic profile of aged skeletal muscle
A list of DIGE-identified protein species with an altered
concentration level in the DT-extracted and AQ fraction from
Fig. 2 – 2-DE analysis of young adult versus old skeletal muscle. Shown are silver-stained 2-DE gels of the detergent (DT; A, B)
and aqueous (AQ; C, D) phase fractions from young adult (A, C) and old (B, D) rat skeletal muscle. Representative gels are shown
for the pH 4–7 and pH 6–11 range. The pH values of the IEF system and molecular mass standards (in kDa) of the 2-DE gels are
indicated on the top and on the left of the panels, respectively.
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Table 1. The table summarizes resultswith respect to the type of
2-DE gel used for protein separation, the type of MS method
employed for protein identification, the protein accession
number of identified muscle proteins, Mascot scores, the
number of matched peptide sequences, the percentage se-
quencecoverage, the actual and theoreticalmolecularmass, theactual and theoretical pI-value, and fold change of individual
proteinsaffectedduringmuscle aging.Data sets frombothpH4–
7 and pH 6–11 gels are combined in the list. The numbering of
distinct 2-D spots of altered density shown in the 4 DIGE Cy5
master gels of Figs. 3 and 4 correlates with the 94 MS-identified
protein species in Table 1. Overall a decreased expression level
was shown for 35 protein spots and an increased concentration
Fig. 3 – DIGE analysis of the detergent-extracted fraction from young adult versus old rat skeletal muscle. Shown are
Cy5-labeled master gels of the detergent-extracted fraction from rat skeletal muscle, covering both the pH 4–7 (A) and pH 6–11
(B) range. Proteins with different expression levels are numbered 1 to 38 and are marked by circles. See Table 1 for a detailed
listing of detergent-extracted proteins with a changed abundance in senescent fibres. The pH values of the IEF system and
molecular mass standards (in kDa) of the 2-DE gels are indicated on the top and on the left of the panels, respectively.
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proteins with an age-related change in abundance ranged in
molecularmass fromapparent 13.6 kDa to 87.5 kDaand covered
a pI-range from approximately 4.7 to 9.2. In the DT fraction,
protein specieswith increased expression levelswere identified
as Coq7 protein, ATP synthase, isocitrate dehydrogenase,
enolase and tropomyosin. Interestingly, differential effects onFig. 4 – DIGE analysis of the aqueous fraction from young adult v
gels of the aqueous fraction from rat skeletal muscle, covering bot
expression levels are numbered 39 to 94 and marked by circles.
proteinswith a changed abundance in senescent fibres. The pH va
of the 2-DE gels are indicated on the top and on the left of the padissimilar 2D spots representing the same protein or protein
complex were observed for muscle creatine kinase, actin and
prohibitin. Several unidentified proteins showed a reduced
abundance in agedmuscle. In the AQ fraction, proteins with an
increased concentration were identified as cytosolic malate
dehydrogenase, triosephosphate isomerase, bile salt sulfotrans-
ferase, PARK7 protein, HHIP-like protein 1, aldolase, pyruvateersus old rat skeletal muscle. Shown are Cy5-labeled master
h the pH 4–7 (A) and pH 6–11 (B) range. Proteins with different
See Table 1 for a detailed listing of aqueous phase-extracted
lues of the IEF system andmolecularmass standards (in kDa)
nels, respectively.
Table 1 – DIGE-identified proteins with a changed abundance in the detergent (DT)-extracted and aqueous (AQ) fraction from young adult versus old rat gastrocnemius
muscle.
Gel Spot
no.
Protein
accession
no.
Name of identified protein Mascot
score
Peptides
matched
Coverage
(%)
Actual
molecular
mass (kDa)
Theoretical
molecular
mass (kDa)
Actual
isoelectric
point (pI)
Theoretical
isoelectric
point (pI)
Fold
change
ANOVA
p<0.5
DT pH 4–7 ESI LC–MS/MS 1 gi|149068153| Demethyl-Q7 (Coq7) 59 3 13 22.9 22.9 6.5 6.1 +1.3 0.037
2 gi|203055| ATP synthase, alpha subunit 363 14 23 39.0 58.9 6.8 9.2 +1.5 0.032
3 – Unknown protein – – – 22.0 – 7.3 – –1.7 0.009
4 gi|6978661| Muscle creatine kinase 82 5 14 43.2 43.2 7.2 6.6 −1.5 0.03
5 gi|6671762| Muscle creatine kinase 75 4 12 45.0 43.3 6.7 6.6 +1.9 0.019
6 gi|6679299| Prohibitin 337 18 74 45.0 29.9 6.0 5.6 +1.4 0.002
7 gi|6679299| Prohibitin 202 10 49 46.0 29.9 6.3 5.6 −2.4 0.033
8 gi|15778719| Tropomyosin, alpha 151 6 20 48.5 32.7 4.5 4.7 +1.2 0.028
9 gi|149049481| Enolase 2, gamma isoform 85 4 13 48.5 33.3 6.3 5.2 +1.4 0.043
10 gi|6679299| Prohibitin 168 5 34 49.5 29.9 6.5 5.6 +2.1 0.037
11 gi|16758446| Isocitrate dehydrogenase 3 343 11 31 50.0 40.1 6.2 6.4 +1.5 0.041
12 gi|149041704| Isocitrate dehydrogenase 3 350 17 36 49.5 39.4 6.3 5.9 +1.5 0.022
13 gi|16758446| Isocitrate dehydrogenase 3 369 11 36 50.5 40.1 6.3 6.5 +1.6 0.037
14 gi|126723393| Enolase 3, beta 222 14 38 55.0 47.3 6.5 7.1 +1.3 0.045
15 gi|16758446| Isocitrate dehydrogenase 3 156 6 24 51.0 40.1 6.2 6.5 +1.2 0.016
16 gi|6978661| Muscle creatine kinase 82 6 14 57.0 43.2 6.2 6.6 +1.7 0.016
17 gi|78365255| Dihydro-lipoamide S-acetyltransferase 160 11 21 67.7 67.7 5.9 8.8 +1.1 0.032
18 – Unknown protein – – – 66.0 – 5.2 – –1.8 0.032
19 – Unknown protein – – – 51.0 – 4.9 – +1.4 0.033
20 gi|1374715| ATP synthase, beta subunit 279 15 35 51.2 51.2 5.2 4.9 +1.4 0.028
21 gi|1374715| ATP synthase, beta subunit 196 12 34 51.2 51.2 5.3 4.9 +1.4 0.011
22 gi|157823033| Actin, beta-2 76 6 15 51.0 42.3 5.4 5.3 +1.4 0.02
23 – Unknown protein – 51.0 – 5.5 – +1.5 0.032
DT pH 6–11 ESI LC–MS/MS 24 gi|149043182| Actin, alpha-1 99 10 36 25.0 51.9 6.8 6.8 −4.7 0.002
25 – Unknown protein – – – 49.0 – 6.2 – −2.4 0.033
26 – Unknown protein – – – 23.0 – 7.6 – −2.4 0.046
27 gi|16758446| Isocitrate dehydrogenase 3 63 3 11 69.0 40.1 9.1 6.5 +2.4 0.044
28 – Unknown protein – – – 62.0 – 6.5 – −2.4 0.009
29 – Unknown protein – – – 68.0 – 6.6 – +2.4 0.02
30 – Unknown protein – – – 54.0 – 6.3 – −2.1 0.009
31 gi|6978661| Muscle creatine kinase 50 4 10 54.0 43.2 6.5 6.6 −1.9 0.043
32 – Unknown protein – – – 49.0 – 6.5 – −1.6 0.006
33 – Unknown protein – – – 57.0 – 8.8 – +1.4 0.04
34 gi|126723393| Enolase 3, beta 276 24 40 68.5 47.3 7.3 7.1 +1.4 0.018
35 – Unknown protein – – – 46.0 – 7.9 – −1.3 0.028
36 – Unknown protein – – – 51.0 – 6.8 – −1.2 0.046
37 gi|126723393| Enolase 3, beta 114 4 17 23.0 47.3 8.0 7.1 +2.5 0.074
38 – Unknown protein – – – 70.0 – 8.1 – +2.4 0.058
AQ pH 4–7 ESI LC–MS/MS 39 – Unknown protein – – – 44.0 – 6.3 – −1.4 0.039
40 – Unknown protein – – – 25.5 – 5.6 – −1.7 0.017
41 – Unknown protein – – – 29.0 – 5.5 – −1.4 0.038
42 gi|205474| Myosin light chain 143 6 36 25.0 20.9 4.1 5.0 −1.7 0.03
43 gi|1213217| Cu/Zn superoxide dismutase 158 6 47 27.5 16.2 6.9 5.7 −1.5 0.013
44 gi|203658| Cu–Zn superoxide dismutase 150 4 32 42.0 15.9 6.8 5.9 +1.5 0.028
45 gi|16924002| Parkinson disease protein 7 88 13 74 44.0 20.2 6.8 6.3 +1.5 0.017
46 – Unknown protein – – – 46.0 – 6.9 – +2.0 0.045
47 gi|16924002| Parkinson disease protein 7 116 6 56 45.0 20.2 4.6 6.3 −1.2 0.025
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48 gi|9507245| Tyrosine 3-monooxygenase/tryptophan
5-monooxygenase activation protein,
gamma subunit
196 10 42 47.5 28.5 4.6 4.8 −1.5 0.017
49 gi|207349| Tropomyosin, alpha 261 19 49 62.0 32.7 4.1 4.7 +1.5 0.019
50 gi|55742832| Annexin A4 282 10 35 51.0 36.2 5.5 5.4 +1.4 0.004
51 gi|37999910 Annexin A4 161 6 26 32.0 36.2 4.0 5.3 −1.6 0.028
52 gi|38512111| Triose phosphate isomerase Tpi1 71 7 33 49.5 27.2 7.3 7.1 +1.3 0.048
53 gi|38512111| Triose phosphate isomerase Tpi1 141 8 52 48.0 27.2 7.4 7.1 +1.4 0.013
54 gi|38512111| Triose phosphate isomerase Tpi1 177 11 62 50.0 27.2 7.3 7.1 +1.2 0.042
55 giI38512111| Triose phosphate isomerase Tpi1 197 6 37 60.0 27.2 5.4 7.1 +1.4 0.011
56 gi|126723393| Enolase 3, beta 417 19 40 70.0 47.3 6.6 7.1 +2.0 0.005
57 gi|126723393| Enolase 3, beta 473 19 38 70.0 47.3 6.3 7.1 +2.1 0.005
58 gi|126723393| Enolase 3, beta 284 10 28 68.5 47.3 5.1 7.1 −1.5 0.018
AQ pH 4–7 MALDI-ToF/ToF MS 59 HSP7C_RAT Heat Shock Protein Hsp71 295 14 23 70.9 70.9 5.7 5.4 −2.7 0.003
60 ALBU_RAT Serum Albumin 182 15 30 69.0 68.7 5.6 6.1 −2.2 0.016
61 ALBU_RAT Serum Albumin 1070 23 48 69.0 68.7 5.8 6.1 +2.1 0.022
62 PGP_RAT Phosphoglycolate phosphatase 182 14 46 24.0 34.5 6.7 5.2 −1.4 0.039
63 ST2A 1_RAT Bile salt sulfotransferase 1 180 3 17 42.0 33.2 6.6 7.7 +2.0 0.022
64 ENOB_RAT Beta Enolase 339 12 37 50.5 46.9 6.7 7.1 +1.8 0.043
65 HIPL1_RAT HHIP-like protein 1 50 14 26 70.0 87.5 6.4 8.5 +1.4 0.035
66 PGP_RAT Phospho glycolate phosphatase 125 7 26 43.0 34.5 5.6 5.2 +1.4 0.048
67 IDH3A_RAT Isocitrate dehydrogenase (NAD) subunit
alpha, mitochondrial
100 4 12 46.5 39.6 7.2 6.5 −1.8 0.010
68 ODP2_RAT Dihydrolipoyl lysine-residue
acetyltransferase pyruvate dehydrogenase
158 9 18 67.0 67.1 6.9 8.8 −2.4 0.023
69 IDH3A_RAT Isocitrate dehydrogenase (NAD) subunit
alpha, mitochondrial
363 10 26 47.0 39.6 7.0 6.5 +1.6 0.048
70 LDHB_RAT Lactate dehydrogenase B Chain 59 10 26 44.0 36.6 6.1 5.7 +1.8 0.014
71 Z354C_RAT Zinc Finger Protein 62 9 23 67.0 64.2 7.3 8.6 −2.2 0.038
72 MDHC_RAT Malate dehydrogenase 64 2 8 46.5 36.5 6.8 6.2 +2.1 0.019
73 CSN4_RAT COP9 signalosome complex subunit 4 279 9 31 49.0 46.3 5.7 5.6 −1.8 0.021
74 CH60_RAT 60 kDa heat shock protein mitochondrial 599 15 35 51.0 60.9 6.2 5.9 −2.6 0.003
75 ENOB_RAT Gamma enolase 169 11 40 49.0 47.1 5.4 5.0 −2.1 0.005
AQ pH 6–11 ESI LC–MS/MS 76 – Unknown protein – – – 71.0 – 7.9 – +3.1 0.009
77 gi|126723393| Enolase 3, beta 314 15 36 49.0 47.3 6.1 7.1 +2.3 0.012
78 gi|55926145| Nucleoside diphosphate kinase B 77 7 51 26.0 17.4 7.2 6.9 −1.9 0.041
79 – Unknown protein – – – 44.0 – 8.0 – +1.7 0.005
80 gi|149041703| Isocitrate dehydrogenase 3 81 2 11 62.0 30.9 6.4 6.0 +1.7 0.016
81 – Unknown protein – – – 21.0 – 8.8 – −1.6 0.013
82 gi|126723393| Enolase 3, beta 122 7 20 51.0 47.3 8.9 7.1 +1.6 0.009
83 – Unknown protein – – – 44.5 – 6.5 – +1.5 0.034
84 gi|16757994| Pyruvate kinase, muscle 130 8 20 61.0 58.3 7.5 6.6 +1.5 0.024
85 gi|109488172| Cofilin-2 90 2 25 57.0 13.6 6.1 8.9 +1.5 0.004
86 Unknown protein – – – 22.0 – 6.7 – −1.5 0.028
87 gi|16757994| Pyruvate kinase, muscle 66 10 28 61.0 58.3 6.9 6.6 +1.5 0.024
88 gi|117935064| Triose phosphate isomerase Tpi1 195 8 41 61.0 27.4 7.1 6.9 +1.4 0.03
89 – Unknown protein – – − 41.0 – 9.2 – +1.4 0.032
90 gi|6978491| Aldo-keto reductase family 1, B1 46 7 16 48.0 36.2 6.1 6.3 −1.4 0.005
91 gi|16757994| Pyruvate kinase, muscle 174 6 15 49.0 58.3 8.4 6.6 +1.3 0.041
92 gi|149067838| Aldolase A 49 4 10 50.0 36.4 9.2 8.5 +1.3 0.038
93 gi|38512111| Triose phosphate isomerase Tpi1 241 12 62 44.0 27.2 7.5 7.1 +1.2 0.043
94 gi|16757994| Pyruvate kinase, muscle 343 13 32 60.5 58.3 9.2 6.6 +1.2 0.026
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1450 J O U R N A L O F P R O T E O M I C S 7 3 ( 2 0 1 0 ) 1 4 4 1 – 1 4 5 3kinase, cofilin-2 and lactate dehydrogenase. Differential effects
on dissimilar 2D spots of the same protein species were shown
for Cu/Zn superoxide dismutase, albumin, enolase, isocitrate
dehydrogenase, annexin A4, and phosphoglycolate phospha-
tase. COP9 signalosome complex subunit 4, Hsp71, mitochon-
drial Hsp60, tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activationprotein, dihydrolipoyllysine-residue
acetyltransferase of the pyruvate dehydrogenase complex, zink
finger protein, nucleoside diphosphate kinase B, myosin light
chain and aldo-keto reductase exhibited a reduced density in
aged muscle. The majority of identified proteins were found to
be involved inmitochondrial metabolism, glycolysis, metabolic
transportation, regulatory processes, the cellular stress re-
sponse, detoxification mechanisms and contraction.
3.5. Immunoblot analysis of age-related changes in the
skeletal muscle proteome
Based on the above shown immunoblotting of abundantmarkers
of the soluble and detergent-extracted cohort of muscle proteins
(Fig. 1C–E), a similar immunodecoration analysis was used toFig. 5 – Immunoblot analysis of the subcellular fractionation of th
skeletal muscle tissue. Shown are expanded views of immuno-d
Ca2+-ATPase isoformSERCA1 (B), heat shock protein Hsp25 (C),mi
(E), prohibitin (F) and malate dehydrogenase (MDH) (G), respectiv
preparations from young muscle (YC), crude preparations from o
muscle (YAQ), aqueous phase-enriched proteins from oldmuscle
(YDT) and detergent phase-enriched proteins from old muscle (O
fractions corresponds with the fractions shown in the silver-stai
found formitochondrial ATP synthase, MDH and SDH, as docume
of antibody labeling in panels (H) to (J). The comparative blotting
(n=5; *p<0.05). Lanes 1 and 2 represent protein fractions from 3-
respectively. 30 μg of protein was loaded per lane per sample fovalidate representative findings from the DIGE analysis of young
adult versus aged muscle tissue. Western blotting revealed
comparable levels of the peripheral protein isoform CSQf of the
Ca2+-binding protein calsequestrin in the AQ phase, as well as
similar levels of the integral Ca2+-ATPase and the stress protein
Hsp25 in the DT phase of 3-month versus 26-month old gas-
trocnemius muscle (Fig. 5A–C). This demonstrates equal loading
of these unaltered proteins during the electrophoretic separation
protocol. In contrast to these muscle proteins, and in agreement
with the DIGE analysis presented here and in previous proteomic
studies [13], ATP synthase, succinate dehydrogenase, prohibitin
and malate dehydrogenase were significantly increased in aged
preparations (Fig. 5D–G). The statistical evaluation is shown for
age-related expression changes in ATP synthase, succinate
dehydrogenase andmalate dehydrogenase (Fig. 5H–J).4. Discussion
The human genome is estimated to contain 25,000 genes of
which approximately 30% encode for membrane-associatede aqueous versus the detergent-extracted fraction from
ecorated bands of the fast CSQf isoform of calsequestrin (A),
tochondrial ATP synthase (D), succinate dehydrogenase (SDH)
ely. The different fractions analyzed represent crude
ld muscle (OC), aqueous phase-enriched proteins from young
(OAQ), detergent phase-enriched proteins from youngmuscle
DT). The general protein expression pattern of the analyzed
ned 1D gel of Fig. 1B. Significant changes in abundance were
nted in the graphical presentation of the statistical evaluation
was statistically evaluated using an unpaired Student's t-test
month versus 26-month old skeletal muscle fibres,
r all immunoblots.
1451J O U R N A L O F P R O T E O M I C S 7 3 ( 2 0 1 0 ) 1 4 4 1 – 1 4 5 3proteins [34]. Integral proteins are both of fundamental
biological importance and represent crucial therapeutic tar-
gets [35], giving central importance to the identification of
their role in aging. However, to date skeletal muscle proteome
studies have mostly investigated soluble proteins thereby
underestimating altered expression levels of integral ele-
ments. In contrast to the proteome-wide analysis of total
tissue extracts, the subproteomic profiling of distinct subsets
of proteins usually provides a reduction in sample complexity
[36]. This can be advantageous for the identification of low-
abundance signature molecules. With respect to muscle
proteomics, the mass spectrometry-based profiling of crude
muscle extracts has decisively advanced basic and applied
myology [13,37,38], but amajor limitation of current proteomic
platforms is their limited dynamic range for resolving complex
protein complements. Crude extract proteomics is therefore
unable to reveal the complete proteome complexity of whole
skeletalmuscles. Recently, major advances have beenmade in
the proteomic profiling of large cellular structures, organelles
and membrane domains from diverse tissue systems [39–41].
Thus, to further advance the analytical capabilities of skeletal
muscle proteomics, the establishment of reproducible sample
fractionation methods that circumvent the introduction of
artifacts is essential in order to enrich membrane-associated
proteins present in muscle fibres.
Here, we have successfully applied a nonionic detergent
phase extraction method for the analysis of the aqueous
versus the membrane-associated fraction from skeletal mus-
cle homogenates. Immunoblotting verified the enrichment of
integral membrane proteins in the detergent-extracted frac-
tion and demonstrated increased expression levels of key
marker proteins in aged muscle, such as prohibitin. Following
separation by standard 2-DE, the abundance of key mitochon-
drial markers, such as ATP synthase and isocitrate dehydro-
genase, was increased in the DT fraction. This would agree
with an age-related shift to more oxidative metabolism in a
slower-twitching fibre population [13–15]. Differential effects
on individual protein spots representing muscle creatine
kinase and prohibitin indicate altered post-translational
modifications, such as phosphorylation patterns, in these
proteins duringmuscle aging [42]. A variety ofmuscle proteins
in the aqueous phase showed varying degrees of alterations in
young adult versus aged muscle, making interpretations on
their role in senescence difficult. However, the increase in
malate dehydrogenase, triosephosphate isomerase, sulfo-
transferase, aldolase, and lactate dehydrogenase in aged
muscle, and the decrease in zink finger protein, nucleoside
diphosphate kinase B and the two stress proteins Hsp71 and
mtHsp60 could be useful for the future establishment of a
biomarker signature of sarcopenia of old age. Identified
muscle proteins with an age-related change in abundance
were shown to be constituents of glycolysis, metabolic
transportation, mitochondrial metabolism, cellular regula-
tion, the stress response, detoxification mechanisms and
fibre contraction.
The slight increase of low-abundance isoforms of pyruvate
kinase in the aqueous phase is an interesting finding, since
previous studies on crude total extracts have shown a
decrease of one of the major sub-species of this glycolytic
enzyme [18]. Pyruvate isoform PK-M1 exists as 5 sub-specieswith differing isoelectric points in skeletal muscle tissues,
whereby theses isozymes display varying degrees of phos-
phorylation and glycosylation [21,24]. Previous studies have
clearly shown that the PK isoform exhibiting a pI of 6.6 and an
apparent molecular mass of 57.8 kDa is several-fold decreased
in senescent muscle fibres [21]. Other PK forms with a more
acidic or basic pI-value did not show major alterations in
concentration levels between crude total protein extracts from
young versus aged muscle [18]. In contrast, the PK isoforms
identified in this study by MS analysis show pI-values of
approximately 6.9, 7.5, 8.4 and 9.2. They therefore represent
different sub-species of pyruvate kinase, as compared to the
major protein previously shown to be reduced during aging.
These findings highlight the potential problems with inter-
preting proteomic data on protein isoforms that exist as
several sub-species in individual tissues. In addition, a large
number of muscle proteins do not exhibit a linear relationship
between molecular mass and their electrophoretic mobility.
This complicates both the internal analysis of protein expres-
sion patterns and the comparison between different proteomic
studies. As can be seen in Table 1, considerable differences can
be detected between the actual and the theoretical molecular
mass of a number of identified proteins. The samewas found in
the case of actual and theoretical pI-values. The reasons for
these apparent discrepancies are that individual 2D spots may
represent degradation products of a larger protein, aggregates
that do not disintegrate during gel electrophoresis and/or
proteins with extensive post-translational modifications.
The proteomic findings presented here suggest thatmuscle
aging is associated with a generally perturbed protein
expression pattern that affects especiallymetabolic pathways.
Most physiological and histological studies of fibre aging
indicate that sarcopenia is due to a multi-factorial pathology.
Skeletal muscle aging is associated with a wide variety of
cellular, biochemical and physiological alterations, including
(i) grouped atrophying fibres, increased numbers of centrally
located nuclei and variability in fibre diameter [9], (ii)
metabolic alterations [43], (iii) mitochondrial disturbances
and an increased susceptibility to apoptosis [44], (iv) a
decreased regenerative capacity [45], (v) disturbed luminal
ion binding and cycling [46], (vi) excitation–contraction
uncoupling [47], (vii) oxidative stress [48], (viii) a blunted
cellular stress response [49], (ix) impaired protein synthesis of
myofibrillar components [50], ( (x) denervation-associated
atrophy [51], (xi) an altered equilibrium of growth factors and
hormones involved in fibre maintenance [52], and (xii) a
severe decline in contractile efficiency [53]. Our proteomic
map of alterations in protein expression in the aqueous versus
detergent-extracted fractions from aged muscle agrees with
the idea of complex biochemical changes in sarcopenia. The
experimental strategy that the subproteomic analysis of
distinct fractions affords a reduction in sample complexity,
thereby potentially revealing novel biomarkers of muscle
aging and impaired muscle function that would otherwise
remain undiscovered, has been substantiated in this report.
As compared to previous whole-proteome investigations [13],
this study has identified novel low-abundance muscle pro-
teins with a changed abundance during muscle aging, such as
Coq7 protein, sulfotransferase, PARK7 protein, HHIP-like
protein 1, zink finger protein, nucleoside diphosphate kinase
1452 J O U R N A L O F P R O T E O M I C S 7 3 ( 2 0 1 0 ) 1 4 4 1 – 1 4 5 3B, aldo-keto reductase and COP9 signalosome complex
subunit 4. The separation of the highly soluble protein
complement from the detergent-extractable protein cohort
has resulted in the enrichment of new biomarker candidates
in both the aqueous and the membrane-associated fractions
from muscle homogenates. The detailed biochemical and cell
biological characterization of these potential signature mole-
cules should help in the establishment of a comprehensive
biomarker collection for sarcopenia-related cellular abnor-
malities. In the long term, established alterations in these
marker proteins will be useful for improving diagnostic
methods, the identification of novel therapeutic targets and
the monitoring of experimental treatments to halt or reverse
age-associated fibre wasting.Acknowledgements
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